日韩精品久久一区二区三区_亚洲色图p_亚洲综合在线最大成人_国产中出在线观看_日韩免费_亚洲综合在线一区

Global EditionASIA 中文雙語Fran?ais
Business

Bayer to invest more in health, nutrition sector

By ZHENG YIRAN | China Daily | Updated: 2025-04-15 00:00
Share
Share - WeChat

Acknowledging China's foreign business environment and opening-up policies for multinational corporations, German life sciences company Bayer is committed to investing in essential health and nutrition solutions in the country in order to serve a broad base of patients, consumers and growers, said its top executive.

"I sincerely appreciate the Chinese government for its recent initiatives aimed at opening up the cell and gene therapy area to foreign investment. The pilot program, introduced by the Chinese government in 2024, is a significant step forward, allowing foreign businesses to participate in the development and commercialization of these groundbreaking therapies," said Bill Anderson, CEO of Bayer.

Anderson made the remarks after he, together with around 40 other representatives of the international business community, met with China's top leadership in Beijing on March 28.

He said China has always encouraged a friendly business environment and opening-up policies for MNCs.

Whether from an innovation or market perspective, China has immeasurable potential and is one of Bayer's important global strategic pillars. The introduction of the 2025 Action Plan for Stabilizing Foreign Investment also allows the company to see more benefits. Relaxed market access, strengthened intellectual property protection, optimized business environment, facilitation of talent exchange, improved supply chain stability and deepened international cooperation will open up greater possibilities for Bayer's development in China, said the company's spokesperson earlier this year.

In 2024 alone, the company initiated several projects in China, including a new consumer health factory in Jiangsu province, with an investment of 600 million yuan ($82.4 million). Last September, it opened Bayer Co Lab in Shanghai, nurturing innovations in cell and gene therapy as well as oncology.

With chronic disease being an increasing challenge in China, Bayer is winning the market, as it has expertise in the prevention and treatment of major chronic diseases such as cardiovascular diseases, stroke and diabetes, bringing new hope for chronic disease management.

And now, with the government's favorable policies, its pace toward innovation is even faster. On Sept 7, the Ministry of Commerce, the National Health Commission, together with the National Medical Products Administration, issued a guideline on carrying out pilot projects to expand opening-up in the medical field, enabling foreign companies to be engaged in the development and application of human stem cell, gene diagnosis and treatment technologies in the pilot free trade zones in Beijing, Shanghai and Guangdong province, as well as Hainan Free Trade Port.

During the meeting in Beijing on March 28, China's top leadership noted that China has been and will remain an ideal, secure and promising destination for foreign investors, and that investing in China is investing in the future.

"The meeting with MNC CEOs signifies its determination in multilateralism and globalization, its opening gesture to the outside world as well as its highlight in cooperation and win-win development. Looking forward, the country should continue to prioritize its business environment, expand market access, enhance policy support and promote international cooperation," said Wang Peng, an associate research fellow at the Beijing Academy of Social Sciences.

In 2024, a total of 59,080 new foreign-invested enterprises were established in China, up 9.9 percent year-on-year. Over the past five years, the return rate of foreign direct investment in the country has remained at approximately 9 percent, ranking among the highest in the world.

 

Bill Anderson, CEO of Bayer

 

 

Bayer's booth at the seventh CIIE in Shanghai in November. CHINA DAILY

 

 

Today's Top News

Editor's picks

Most Viewed

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
主站蜘蛛池模板: 午夜不卡一区二区 | 欧洲免费无线码二区5 | 视频一区二区久久 | 可米影院 | 欧美午夜精品久久久久免费视 | 欧美高清不卡午夜精品免费视频 | 国产综合欧美 | 日韩欧美一区二区视频 | 久久99国产综合精品免费 | 日本久久精品免视看国产成人 | 国产精品视频网 | 国产 AV 仑乱内谢 | 久久久久毛片免费观看 | 亚洲视频 中文字幕 | 亚洲国产精品综合久久网络 | 狠狠干2020 | 免费av在线播放 | 免费在线一区二区 | 二级毛片视频 | 亚洲成a人v在线观看 | 欧美一级黄色影院 | 一区二区久久 | 国产午夜精品一区二区三区嫩草 | 欧美在线视频一区二区 | 天天干天天爱天天操 | 国产精品久久久久久久久久久搜索 | 久久AV亚洲精品一区无码 | 成人久久久久久久久 | 国产精品亚洲视频 | 国产精品原创巨作av | 天堂网中文字幕 | 日本成人一区二区三区 | 日韩三级在线播放 | 97超级碰碰视频在线 | 刮伦人妇A片1级 | 欧美国产视频 | 国产成人微拍精品 | 我要看免费毛片 | 亚洲浮力影院 | 欧美一级视频 | 日韩视频www |